• Ingevity forecast 2026 adjusted EBITDA margin of about 35%.
• Expected 2026 free-cash-flow yield of about 10%.
• Target leverage ratio of 2-2.5x.
• Plan calls for about $1 billion of deployable cash over 2026-2027 to fund growth, reduce debt, return capital.
• 2025 baseline: net sales $1.2 billion, adjusted EBITDA $373 million, free cash flow $273.5 million, operating cash flow $331.2 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ingevity Corporation published the original content used to generate this news brief on July 02, 2026, and is solely responsible for the information contained therein.